Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
about
Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.Colorectal liver metastases.Management of symptomatic locoregional recurrence during regional chemotherapy for colorectal liver metastases.Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.Measurement of response to treatment in colorectal liver metastases.
P2860
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@en
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@nl
type
label
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@en
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@nl
prefLabel
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@en
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@nl
P1476
Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?
@en
P2093
Allen-Mersh TG
Dworkin MJ
P304
P356
10.1016/0305-7372(91)90013-P
P577
1991-12-01T00:00:00Z